Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $156.84 and last traded at $155.12, with a volume of 37003 shares. The stock had previously closed at $156.39. Analysts Set New Price Targets Several equities research analysts […]
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The company traded as high as $156.84 and last traded at $155.12, with a volume of 37003 shares traded. The stock had previously closed at $156.39. Analyst Upgrades and Downgrades A number of research firms […]
Artisan Partners Limited Partnership lowered its position in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 3.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,995,408 shares of the biotechnology company’s stock after selling 227,043 shares during the period. […]
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)’s stock price reached a new 52-week high during trading on Thursday . The company traded as high as $141.81 and last traded at $141.63, with a volume of 617323 shares trading hands. The stock had previously closed at $129.93. Analysts Set New Price Targets Several analysts have […]
Shares of Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 […]